Pershing Square, Valeant arrive at settlement split for Allergan lawsuit

(Reuters) – Activist investor William Ackman’s Pershing Square PHS.AS and Valeant Pharmaceuticals (VRX.TO) on Friday decided to pay $290 million to settle a lawsuit that accused them of insider trading before bidding for Allergan Plc (AGN.N) in 2014. Pershing Square said it...

from http://ift.tt/2lnsJAp